JAM
RCUS icon

Jupiter Asset Management’s Arcus Biosciences RCUS Stock Holding History

Jupiter Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,567
Closed -$872K – 524
2023
Q3 		$872K Hold
48,567
– – 0.01% 411
2023
Q2 		$986K Buy
48,567
+6,333
+15% +$121K 0.01% 431
2023
Q1 		$770K Buy
+42,234
New +$807K 0.01% 355

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jupiter Asset Management's RCUS Position: Q4 2023 in Review

Jupiter Asset Management sold out of Arcus Biosciences (RCUS) in Q4 2023, closing a stake of 48,567 shares — an estimated $872K sold.

Jupiter Asset Management first reported a position in RCUS in Q1 2023 and held it in 3 quarters. The position peaked at $986K in Q2 2023. 185 funds tracked by Wall St. Rank hold RCUS as of Q4 2023.

  • Jupiter Asset Management reported no remaining Arcus Biosciences position as of Q4 2023 after selling out during the quarter.
  • Jupiter Asset Management sold 48,567 Arcus Biosciences shares in Q4 2023, an estimated $872K.
  • Jupiter Asset Management first reported a position in Arcus Biosciences in Q1 2023 and held it in 3 quarters.
  • Jupiter Asset Management's Arcus Biosciences position peaked at $986K in Q2 2023.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2023.

Based on Jupiter Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.